Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Qing-Lian Chen, Qian Yan, Kun-Liang Feng, Chun-Feng Xie, Chong-Kai Fang, Ji-Nan Wang, Li-Hua Liu, Ya Li & Chong Zhong. (2021) Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma. International Journal of General Medicine 14, pages 805-823.
Read now
Read now
Michael John Peck, Edward B. Sanders, Gerhard Scherer, Frank Lüdicke & Rolf Weitkunat. (2018) Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products. Biomarkers 23:3, pages 213-244.
Read now
Read now
Massimo Franchini & Giuseppe Lippi. (2013) Pharmacotherapy of von Willebrand disease. Expert Opinion on Orphan Drugs 1:6, pages 481-489.
Read now
Read now
Massimo Franchini & Giuseppe Lippi. (2007) The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complex. Biologics: Targets and Therapy 1:3, pages 285-289.
Read now
Read now
Articles from other publishers (19)
Rahmat Yusni, Silmi Mariya, Uus Saepuloh, Sela S. Mariya & Huda S. Darusman. (2023)
Kidney cell culture
Macaca fascicularis
as a candidate for vaccine development and in vitro model
. Journal of Medical Primatology 52:4, pages 213-222.
Crossref
Crossref
Renjith P Nair, Lekshmi P & Anugya Bhatt. 2022. Biomedical Product and Materials Evaluation. Biomedical Product and Materials Evaluation
231
257
.
Nikhita Gogate, Daniel Lyman, Amanda Bell, Edmund Cauley, Keith A Crandall, Ashia Joseph, Robel Kahsay, Darren A Natale, Lynn M Schriml, Sabyasach Sen & Raja Mazumder. (2021) COVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data model. Briefings in Bioinformatics 22:6.
Crossref
Crossref
Emily Wilson, Fayez Hanna, Annemarie Hyppa, Ella Orlowski, Hizb U. Dawar, Zar Sanga, Amanda Dennis, Toly Pavlov & Alhossain A. Khalafallah. (2021) Assessment of von Willebrand disease and pregnancy outcomes at regional Australian hospitals. European Journal of Haematology 106:4, pages 456-466.
Crossref
Crossref
Marianne E. Nome, Leslie R. Euceda, Shakila Jabeen, Julia Debik, Tone F. Bathen, Guro F. Giskeødegård, Kristin A. Taskén, Gunhild M. Mælandsmo, Bente Halvorsen, Arne Yndestad, Elin Borgen, Øystein Garred, Pål Aukrust, Thor Ueland, Olav Engebraaten, Vessela N. Kristensen & Xavier Tekpli. (2019) Serum levels of inflammation‐related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers. International Journal of Cancer 146:1, pages 223-235.
Crossref
Crossref
Rena Kasimu, Xinling Wang, Xiaomei Wang, Junping Hu, Xiaoqing Wang & Yuming Mu. (2018) Antithrombotic effects and related mechanisms of Salvia deserta Schang root EtOAc extracts. Scientific Reports 8:1.
Crossref
Crossref
Massimo Franchini & Giuseppe Lippi. (2016) Inside out the thrombus: Defining the role of von Willebrand factor. Thrombosis Research 144, pages 234-235.
Crossref
Crossref
Wolfgang Miesbach, Stefanie Krekeler, Zsuzsanna Wolf & Erhard Seifried. (2015) Clinical use of Haemate® P in von Willebrand disease: A 25-year retrospective observational study. Thrombosis Research 135:3, pages 479-484.
Crossref
Crossref
Yi Liu, Xiwei Wang, Sanglin Li, Huaidong Hu, Dazhi Zhang, Peng Hu, Yixuan Yang & Hong Ren. (2014) The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: A quantitative proteomic based study. Journal of Proteomics 106, pages 99-112.
Crossref
Crossref
Massimo Franchini & Pier Mannuccio Mannucci. (2013) Von Willebrand disease‐associated angiodysplasia: a few answers, still many questions. British Journal of Haematology 161:2, pages 177-182.
Crossref
Crossref
Massimo Franchini, Francesco Frattini, Silvia Crestani, Carlo Bonfanti & Giuseppe Lippi. (2013) von Willebrand factor and cancer: A renewed interest. Thrombosis Research 131:4, pages 290-292.
Crossref
Crossref
Md. Imtaiyaz Hassan, Aditya Saxena & Faizan Ahmad. (2012) Structure and function of von Willebrand factor. Blood Coagulation & Fibrinolysis 23:1, pages 11-22.
Crossref
Crossref
Emmanuel J. Favaloro, Giuseppe Lippi & Massimo Franchini. (2010) Contemporary platelet function testing. Clinical Chemistry and Laboratory Medicine 48:5.
Crossref
Crossref
Massimo Franchini, Giovanni Targher, Martina Montagnana & Giuseppe Lippi. (2008) Antithrombotic prophylaxis in patients with von Willebrand disease undergoing major surgery: when is it necessary?. Journal of Thrombosis and Thrombolysis 28:2, pages 215-219.
Crossref
Crossref
M. FRANCHINI, M. MONTAGNANA & G. LIPPI. (2008) Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease. International Journal of Laboratory Hematology 30:2, pages 91-94.
Crossref
Crossref
Mari TerashimaHiroshi KataokaHirosei HorikawaHiroyuki NakagawaToshiaki TaokaMasanori MatsumotoKozue SaitoKimihiko KichikawaSatoshi Ueno. (2008) Cerebral Sinus and Venous Thrombosis Associated with von Willebrand Factor, Independently of Factor VIII. Clinical Medicine: Case Reports 1, pages CCRep.S737.
Crossref
Crossref
Massimo Franchini, Giuseppe Lippi, Dino Veneri, Giovanni Targher, Marco Zaffanello & Gian Cesare Guidi. (2008) Inherited platelet disorders. Clinica Chimica Acta 387:1-2, pages 1-8.
Crossref
Crossref
Sébastien Lacroix-Desmazes, Yohann Repessé, Srinivas V. Kaveri & Suryasarathi Dasgupta. (2008) The role of VWF in the immunogenicity of FVIII. Thrombosis Research 122, pages S3-S6.
Crossref
Crossref
Massimo Franchini, Giovanni Targher & Giuseppe Lippi. (2007) Prophylaxis in von Willebrand disease. Annals of Hematology 86:10, pages 699-704.
Crossref
Crossref